BFA
ADMS

BlackRock Fund Advisors’s Adamas Pharmaceuticals ADMS Stock Holding History

BlackRock Fund Advisors’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$14.4M Buy
854,745
+97,272
+13% +$1.5M ﹤0.01% 2365
2016
Q3 		$12.4M Buy
757,473
+52,736
+7% +$802K ﹤0.01% 2338
2016
Q2 		$10.7M Buy
704,737
+117,550
+20% +$1.94M ﹤0.01% 2377
2016
Q1 		$8.49M Buy
587,187
+97,698
+20% +$1.65M ﹤0.01% 2454
2015
Q4 		$13.9M Buy
489,489
+230,928
+89% +$3.89M ﹤0.01% 2259
2015
Q3 		$4.33M Sell
258,561
-5,670
-2% -$129K ﹤0.01% 2869
2015
Q2 		$6.93M Buy
264,231
+185,111
+234% +$3.6M ﹤0.01% 2717
2015
Q1 		$1.38M Sell
79,120
-617
-0.8% -$10.6K ﹤0.01% 3187
2014
Q4 		$1.39M Buy
79,737
+16,072
+25% +$244K ﹤0.01% 3202
2014
Q3 		$1.19M Sell
63,665
-607
-0.9% -$10.4K ﹤0.01% 3182
2014
Q2 		$1.18M Buy
+64,272
New +$1.15M ﹤0.01% 3155

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

BlackRock Fund Advisors's ADMS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Adamas Pharmaceuticals (ADMS) stake by 13% in Q4 2016, buying an estimated $1.5M and bringing the position to 854,745 shares worth $14.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

BlackRock Fund Advisors first reported a position in ADMS in Q2 2014 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • BlackRock Fund Advisors held 854,745 shares of Adamas Pharmaceuticals worth $14.4M as of Q4 2016.
  • BlackRock Fund Advisors bought 97,272 Adamas Pharmaceuticals shares in Q4 2016, an estimated $1.5M.
  • Adamas Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2365 holding.
  • BlackRock Fund Advisors first reported a position in Adamas Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.